Registry following people with Wolfram syndrome and related WFS1 disorders
Collects health history and genetic testing from people with Wolfram syndrome and their families.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Registry title
- Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
- Status
- Recruiting
- People taking part
- 5,000 people, planned
- Started
- Jul 2011
- Expected to end
- Apr 2027
- Type of study
- Observational
- Record updated
- 23 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people of any age with Wolfram syndrome. Unaffected parents, brothers, sisters and spouses can join as controls.
- Age
- From birth (0 Years); no upper age limit is given. Children can join.
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of Wolfram syndrome. This means 2 major signs (diabetes mellitus before age 16, optic atrophy before age 16), or 1 major sign plus 2 minor signs, or 2 disease-causing WFS1 or CISD2 gene changes.
- Biomarker or test result
- Minor signs include 1 loss of function mutation in WFS1/CISD2 or a family history of Wolfram syndrome. Two disease-causing WFS1 or CISD2 mutations are enough on their own. Blood for WFS1 gene testing is taken if not already done.
Main reasons for not taking part
- Cannot get help with translation, so cannot understand the questionnaire
- Unaffected family members who cannot understand the Informed Consent Document
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Major Criteria
- Diabetes mellitus <16 yrs
- Optic atrophy <16 yrs; Minor Criteria
- Diabetes insipidus
- Diabetes mellitus >16yrs
- Optic atrophy >16 yrs
- Sensorineural deafness
- Neurological signs (ataxia, epilepsy, cognitive impairment)
- Renal tract abnormalities (structural or functional)
- 1 loss of function mutation in WFS1/CISD2 AND/OR family history of Wolfram syndrome; Minimum Required
- 2 major OR
- 1 major plus 2 minor criteria OR
- 2 pathological WFS1 or CISD2 mutations are identified; Other variable suggestive evidence
- Hypogonadism (males)
- An absence of type 1 diabetes auto-antibodies
- Bilateral cataracts
- Psychiatric disorder
- Gastrointestinal
Who cannot take part
- Inability of a patient and/or a guardian to obtain help with translation and thus, inability to understand questionnaire
- Parent, Sibs, and Spouses:
- Parents, sibs, and spouses that are unaffected will be recruited as controls. Inclusion criterion is having the unaffected status and exclusion criterion is if the person cannot understand the Informed Consent Document
Other criteria
- Any patient worldwide with a diagnosis of Wolfram syndrome and with access to the Internet can be enrolled in the Registry. Since the disease usually manifests in the first decade of life and tends to have an inevitably progressive course, participation of minors is important for establishing the natural course of the disease
Where in United States
- Washington University School of MedicineSt Louis, United StatesContact: Fumihiko Urano, MDTaking people
About the trial
What the trial wants to find out
In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide important insights into the more complex type 1 and type 2 diabetes mellitus.
Read full original descriptionShow less
Aim 1. Establish and maintain a registry of patients with Wolfram syndrome. An Internet based registry will be employed to enroll participants with the clinical diagnosis of Wolfram syndrome (insulin dependent DM and bilateral OA). Clinical information regarding age of diagnosis and progression of the disease will be collated and analyzed to better define its natural history, along with potential metabolic phenotypes such as glucose intolerance of heterozygous parents and unaffected sibs.
If not already completed, blood for WFS1 sequence analysis will be obtained on the participants (parents and sibs also for control purposes) and sent to a CLIA certified lab to define the mutation. This information will benefit patient families and referring physicians by providing a genetic diagnosis and where indicated. The Wolfram Syndrome Registry will foster international collaborations to more efficiently and systematically collect Wolfram syndrome patients and their clinical and experimental data.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
- Plain-language title
- Registry following people with Wolfram syndrome and related WFS1 disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 23 December 2025